CareLit · DOI-Nachweis · Ultraschall in der Medizin - European Journal of Ultrasound
Healthy controls have the same hepatic transit time (HTT) using SonoVue® and Luminity® but using Levovist® the HTT is significantly longer
DOI 10.1055/s-2007-988997
Bibliografische Angaben
Nachweis in CareLit
Autor:innenT Haendl, D Strobel, K Esser, M Frieser, T Bernatik
ZeitschriftUltraschall in der Medizin - European Journal of Ultrasound
Ausgabe10/2007
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Objective: Liver metastases lead to a shortening of the HTT of an echo enhancer. Former studies using Optison® showed a HTT of about 16s in healthy controls. Optison is currently unavailable and recent observations indicated that SonoVue® has a shorter HTT than Optison®. Hence we compared the HTT of present available contrast agents in healthy controls. Method: 15 healthy controls with no visible liver lesions were…
Zitieren
Zitierempfehlung
T Haendl, D Strobel, K Esser, M Frieser, T Bernatik (2007) Healthy controls have the same hepatic transit time (HTT) using SonoVue® and Luminity® but using Levovist® the HTT is significantly longer. Ultraschall in der Medizin - European Journal of Ultrasound (10). https://doi.org/10.1055/s-2007-988997
Mit CareLit weiterarbeiten